Zobrazeno 1 - 5
of 5
pro vyhledávání: '"den Breeijen, Johanna H."'
Autor:
Klipstein-Grobusch, Kerstin, Geleijnse, Johanna M, den Breeijen, Johanna H, Boeing, Heiner, Hofman, Albert, Grobbee, Diederick E, Witteman, Jacqueline CM
Publikováno v:
In The American Journal of Clinical Nutrition February 1999 69(2):261-266
Autor:
Udo, Renate, Maitland-van der Zee, Anke H., Egberts, Toine C. G., den Breeijen, Johanna H., Leufkens, Hubert G. M., van Solinge, Wouter W., De Bruin, Marie L., Sub Pharmacoepidemiology, Sub Pharmacotherapy, Theoretical, Sub Clinical Pharmacy, Pharmacoepi, Sub Gen. Pharmacoepi and Clinical Pharm, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Pharmacoepidemiology and Drug Safety, 25(Suppl. S1). John Wiley and Sons Ltd
Purpose: The development and validation of algorithms to identify cases of idiopathic acute liver injury (ALI) are essential to facilitate epidemiologic studies on drug-induced liver injury. The aim of this study is to determine the ability of diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::1fe93e3a3e034c04c62654287a1f2a6e
https://dspace.library.uu.nl/handle/1874/345897
https://dspace.library.uu.nl/handle/1874/345897
Autor:
Geleijnse, Johanna M., Witteman, Jacqueline CM., den Breeijen, Johanna H., Hofman, Albert, de Jong, Paulus T.V.M., Pols, Huib A.P., Grobbee, Diederick E., Geleijnse, J M, Witteman, J C, den Breeijen, J H, Hofman, A, de Jong, P T, Pols, H A, Grobbee, D E
Publikováno v:
Journal of Hypertension; Jun1996, Vol. 14 Issue 6, p737-741, 5p
Autor:
de Rijk, Maarten C., Breteler, Monique M. B., den Breeijen, Johanna H., Launer, Lenore J., Grobbee, Diederick E., van der Meché, Frans G. A., Hofman, Albert
Publikováno v:
Archives of Neurology; June 1997, Vol. 54 Issue: 6 p762-765, 4p
Autor:
Udo R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., Maitland-van der Zee AH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands., Egberts TC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, The Netherlands., den Breeijen JH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, The Netherlands., Leufkens HG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., van Solinge WW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., De Bruin ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2016 Mar; Vol. 25 Suppl 1, pp. 21-8. Date of Electronic Publication: 2015 Jul 05.